Influence of ramipril on the course of plasma thrombomodulin in patients with diabetes mellitus

Vasa - Journal of Vascular Diseases

Volumn 28, Issue 3, 1999, Pages 172-180

  Borcea, V ^d   Morcos, M ^c   Isermann, B ^d   Henkels, M ^d   Ziegler, S ^d   Zumbach, M ^d   Amiral, J ^a   Langst K D ^b   Seiz, W ^b   Ziegler, R ^d   Wahl, P ^d   Nawroth, P P ^d  

^a Serbio Research Laboratory   (France)

^b SANOFI   (France)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d NONE

Author keywords

Angiotensin converting enzyme inhibitor; Diabetes mellitus; Diabetic nephropathy; Endothelium; Microvascular diabetic complications; Thrombomodulin

Indexed keywords

ALBUMIN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; RAMIPRIL; THROMBOMODULIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CELL DAMAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; ENDOTHELIUM CELL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PROSPECTIVE STUDY; PROTEINURIA;

EID: 0032794198     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.28.3.172     Document Type: Article

References (40)

1. Amiral J, Adam M, Mimilla F, Larrivaz I, Chambrette B, Boffa MC. Design and validation of a new immunoassay for soluble forms of thrombomodulin and studies on plasma. Hybridoma 1994; 13: 205-213.
2. Amiral J, Adam M, Mimilla F, Larrivaz I, Plassart V, Grosley M, Chambrette B, Boffa MC. Measurement of soluble forms of thrombomodulin in plasma. Blood, coagulation & fibrinolysis 1990; 1; 735.
3. Boehme MW, Deng Y, Raeth U, Bierhaus A, Ziegler R, Stremmel W, Nawroth PP. Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies. Immunology 1996; 87: 134-140.
4. Brenna S, Prencipe L, Montalbetti N, Perlangeli V, Palpon R. Assessing the automatic DIAMAT liquid chromatograph for glycated hemoglobins. Clin. Chem 1986; 32: 896.
5. Brownlee M, Cerami A, Vlassara H. Advanced glycosilation endproducts in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315-1320.
6. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219-226.
7. Dittman WA, Majerus PW. Structure and function of thrombomodulin: a natural anticoagulant. Blood 1990; 75: 239-236.
8. Donatelli M, Hoffmann E, Colletti I, Andolina G, Russo V, Bucalo ML, Valenti TM, Compagno V, Cataldo MG, Morici ML. Circulating endothelin-1 levels in type 2 diabetic patients with ischeamic heart disease. Acta Diabetol 1996; 33: 246-248.
9. Dusting GJ, Hyland R, Hickey H, Makadissi M. Angiotensin-converting enzyme inhibitors reduce neointimal thickening and maintain endothelial nitric oxide function in rabbit carotid arteries. Am J Cardiol 1995; 76: 24-27.
10. Esmon CT. The regulation of natural anticoagulant pathways. Science 1987; 235: 1348-1352.
11. Esposito C, Gerlach H, Brett J, Stern D, Vlassara H. Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 1989; 170: 1387-1407.
12. Gabat S., Keller C, Kempe Hp, Amiral J, Ziegler R, Ritz E, Bergis KH, Wahl P, Nawroth P, Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus. Vasa 1996; 25: 233-241.
13. Gruden G, Gavalio-Perin P, Bazzan M, Stella S, Vuolo A, Pagano G. PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes 1994; 43: 426-429.
14. Gruden G, Pagano G, Romagnoli R, Frezet D, Olivetti C, Cavallano-Perin P. Thrombomodulin levels in insulin-dependent diabetic patients with microalbuminuria. Diabetic Medicine 1995; 12: 258-260.
15. Hergesell O, Andrassy K, Geberth S, Nawroth P, Gabath S. Plasma thrombomodulin levels are dependent on renal function. Thromb Res 1993; 72: 455-458.
16. Hofman MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Fiehn W, Ziegler R, Wahl P, Nawroth PP. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. In press Diabetes Care 1997.
17. Ishii M, Uchiyama H, Kazama M. Soluble thrombomodulin antigen in conditioned medium is encreased by damage of endothelial cells. Thromb Haemostas 1991; 65: 618-623.
18. Iwashima Y, Sato K, Watanabe K, Ooshima E, Hiraishi S, Ishii H, Kazama M, Makino I. Elevation of plasma thrombomodulin levels in diabetic patients with early diabetic nephropathy. Diabetologia 1990; 39: 983-987.
19. Juan-Vague I, Roul C, Alessi MC, Ardissone JP, Heim M, Vague P. Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients - relationship with plasma insulin. Thromb Haemost 1989; 61: 370-373.
20. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H. Advanced protein glucosylation induces transendothelial human monocyte chemotaxis and secretion of plateled-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 1990; 87: 9010-9014.
21. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. Duxbury Press, Belmont, California, 1988.
22. Little RJA, Rubin DB. Statistical analysis with missing data. John Wiley & Sons, Inc, 1987.
23. Lorenzi M, Cagliero E. Pathobiology of endothelial and other vascular cells in diabetes mellitus. Diabetes 1991; 40: 653-659.
24. Mansfield MW, Stickland MH, Grant PJ. PAI-1 concentrations in first-degree relatives of patients with non-insulin-dependent diabetes: metabolic and genetic associations. Thromb Haemost 1997; 77: 357-361.
25. Nordt TK, Klassen KJ, Schneider DJ, Sobel BE. Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis. Arterioscl Thromb 1993; 13: 1822-1827.
26. O'Driscoll, Green D, Rankin J, Stanton K, Tylor R. Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J Clin Invest 1997; 100: 678-684.
27. Parving HH, Nielsen FS, Bang LE, Smidt UM, Svendsen TL, Chen JW, Gall MA, Rossing P. Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy. Diabetologia 1996; 39: 1590-1597.
28. Pepine CJ. Improved endothelial function with angiotensin-converting enzyme inhibitors. Am J Cardiol 1997; 79 (5A): 29-32.
29. Perfetto F, Tarquini R, de Leonardis V, Piluso A, Lombardi V, Tarquini B. Angiopathy affects circulating endothelin-1 levels in type 2 diabetic patients. Acta Diabetol 1995; 32: 263-267.
30. Porta M, La Selva M, Molinatti GM. Endothelial cell function in diabetic microangiopathy. Diabetologia 1987; 30: 601-609.
31. Rinno H, Kuramoto T, lijima T, Yagame M, Tomino Y. Measurement of soluble thrombomodulin in sera from various clinical stages of diabetic nephropathy. J Clin Lab Anal 1996; 10: 119-124.
32. Sernau T, Wilhelm C, Seyfert U, Gabath S, Henkels M, Amiral J, Bergis KH, Ziegler R, Wahl P, Nawroth PP. Thrombomodulin is a marker for microvascular, but not for macrovascular endothelial cell damage. Vasa 1995; 24: 347-353.
33. Smulders YM, Rakic M, Stehouwer CDA, Weijers RNM, Slaats EH, Silberbusch J. Determinants of progression of microalbuminuria in patients with NIDDM. Diabetes Care 1997; 20: 999-1005.
34. Stehouwer CDA, Lambert J, Donker AMJ, van Hinsbergh VWM. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997; 34: 55-68.
35. Stehouwer CDA, Stroes ESG, Hackeng WHL, Mulder PGH, Den Ottolander GJH. Von Willebrand Factor and development of diabetic nephropathy in IDDM. Diabetes 1991; 40: 971-976.
36. Stehouwer CDA, Zellenrath P, Polak BCP, Baarsma GS, Nauta JJP, Donker AJM, Den Ottolander GJH. Von Willebrand Factor and early diabetic retinopathy: no evidence for a relationship in patients with type I (insulin-dependent) diabetes mellitus and normal urinary albumin excretion. Diabetologia 1992; 35: 555-559.
37. Takahashi K, Ghatei MA, Lam HC, O'Halloran DJ, Bloom SR. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 1990; 33: 306-301.
38. Tanaka A, Ishii H, Hiraish S, Kazama M, Maezawa H. Increased thrombomodulin values in plasma of diabetic men with microangiopathy. Clin Chem 1991; 37: 269-272.
39. Yaqoob M, Patrick AW, McClelland P, Stevenson A, Mason H, White MC, Bell GM. Relationship between markers of endothelial dysfunction, oxidant injury and tubular damage in patients with insulin-dependent diabetes mellitus. Clin Sci Colch 1993; 85: 557-562.
40. Yokoyama H, Tomonaga O, Hirayama M, Ishii A, Takeda M, Babazono T, Ujihara U, Takahashi C, Omori Y. Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients. Diabetologia 1997; 40: 405-411.